| Date Filed | Type | Description |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. reports a 0% stake in Albany Molecular Research Inc. |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/05/2017 |
SC 13D/A
| D'Ambra David reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
SC 13D/A
| D AMBRA CONSTANCE M reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
SC 13D/A
| Marth William S reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
SC 13D/A
| 3-Gutiver, S.L. reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
SC 13D/A
| D AMBRA THOMAS E reports a 0% stake in Albany Molecular Research, Inc. |
| 08/31/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/31/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/31/2017 |
8-K
| Quarterly results |
| 08/18/2017 |
8-K
| Quarterly results |
| 08/09/2017 |
10-Q
| Quarterly Report for the period ended June 30, 2017 |
| 08/04/2017 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/17/2017 |
GN
| The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Albany Molecular Research, Inc. – AMRI |
|